Feb 16 • 03:55 UTC 🇱🇻 Latvia LSM

In Latvia, Borrelia proteins are being studied to improve the vaccine against Lyme disease

Research in Latvia is focused on Borrelia proteins as potential components for enhancing Lyme disease vaccines.

In Latvia, researchers are investigating Borrelia proteins, which are linked to Lyme disease, the most common tick-borne infection in the Northern Hemisphere, affecting over 14% of the world's population. Last year, more than 500 cases were reported in Latvia, doubling the number from 2023. If left untreated, Lyme disease can lead to severe health issues such as joint pain, heart palpitations, and other adverse conditions.

📡 Similar Coverage